Obayashi to Acquire Multiplex in $526M Expansion Deal 
Qantas Unveils Wellness-Focused Nonstop Sydney-London Flights to Reduce Jet Lag 
Hyundai to Acquire SoftBank’s Remaining Boston Dynamics Stake for $325 Million 
John Jumper Leaves Google DeepMind for Anthropic Amid Intensifying AI Talent Race 
Carro Expands Into Australia With Acquisition of Used-Car Platform CarPlace 
HSBC Australia Faces A$35M Penalty Over Scam Protection Failures 
Chinese Social Media Giant Xiaohongshu Eyes Hong Kong IPO at Over $70 Billion Valuation 
SpaceX Surpasses Amazon in Market Value as Post-IPO Rally Accelerates 
Ukrainian Drone Makers Target Japan and Asia Defense Market 
G7 Explores AI Access Deal With U.S. Amid Anthropic Restrictions 
Jio IPO Filing Nears as Reliance Targets $4 Billion Market Debut 
Samsung Gains Interest from BYD, Google, AMD as AI Chip Demand Strains TSMC Capacity 
SpaceX Stock Slides After IPO Rally as Valuation Concerns Grow 
Kingboard Holdings Shares Surge After HK$11.77 Billion Block Trade to Expand PCB and AI Supply Chain Business 
J.P. Morgan Sees Potential Vestas Guidance Upgrade Amid Strong Wind Energy Demand 
SK Hynix Shares Hit Record High After Shipping Next-Generation HBM4E AI Memory Samples 
US Raises Concerns Over Possible ASML EUV Machine Transfer to China 
FORT MYERS, Fla., Jan. 12, 2016 (GLOBE NEWSWIRE) -- 21st Century Oncology Holdings, Inc. (the "Company"), the largest global, physician-led provider of integrated cancer care services, commented today on recently passed legislation ahead of its presentation at the 34th Annual J.P. Morgan Healthcare Conference on January 12th, 2016 at 1:30pm PT / 4:30pm ET, where it will discuss the benefits of this new bill.
The United States Congress unanimously passed the Patient Access and Medicare Protection Act (S. 2425) which freezes radiation oncology freestanding payment rates for treatment delivery and image guidance codes in 2017 and 2018 at levels set for 2016. CMS will transition to a new episodic alternative payment model in 2019. The codes in the bill that are expressly protected are G6001 to G6015, which include IMRT, conformal and IGRT treatment. The bill was signed into law by President Obama on December 28, 2015.
The legislation also requires the Secretary of Health and Human Services (HHS) to submit to Congress a report on the development of an episodic alternative payment model for reimbursement under the Medicare program within 18 months.
Dr. Daniel Dosoretz, Founder, Chief Executive Officer and President, commented, “We applaud Congress and President Obama for their dedication to working together with the industry to advance payment reform and achieve payment predictability while ensuring patient access to quality cancer care. This is an exceptional example of how bipartisan collaboration can deliver a meaningful benefit to patients in need of the most advanced technologies available in radiation therapy. We look forward to working with policymakers over the next few years on developing an alternative payment model which will provide continued access to sophisticated radiation therapy treatment for patients for years to come.”
About 21st Century Oncology Holdings, Inc.
21st Century Oncology Holdings, Inc. is the largest global, physician led provider of integrated cancer care services. The Company offers a comprehensive range of cancer treatment services, focused on delivering academic quality, cost-effective patient care in personal and convenient settings. As of September 30, 2015, the Company operated 182 treatment centers, including 146 centers located in 17 U.S. states and 36 centers located in seven countries in Latin America.
21st Century Oncology Contact: LeAnne M. Stewart Chief Financial Officer 239-931-7281 [email protected] Investor Contact: The Ruth Group Nick Laudico 646-536-7030 [email protected] Brandon Vazquez 646-536-7032 [email protected]
